GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jul 1, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on July 1, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine filing reporting on share transactions, not indicating new risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Merrill Lynch International (company) — Corporate stockbroker
- July 1, 2025 (date) — Date of announcement and purchase
FAQ
What was the specific number of GSK plc ordinary shares purchased?
The filing states that a 'number' of ordinary shares were purchased but does not specify the exact quantity.
What was the total dollar amount spent on the share repurchase?
The filing does not disclose the total dollar amount of the share repurchase.
Who acted as GSK plc's corporate stockbroker for this transaction?
Merrill Lynch International acted as the Company's corporate stockbroker.
On what date did the share purchase occur?
The filing indicates the purchase occurred on or around July 1, 2025.
What is the par value of GSK plc's ordinary shares?
The ordinary shares are of 31¼ pence each.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 1, 2025 regarding GSK plc (GLAXF).